Correlation Between Arcticzymes Technologies and Ultimovacs ASA
Can any of the company-specific risk be diversified away by investing in both Arcticzymes Technologies and Ultimovacs ASA at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Arcticzymes Technologies and Ultimovacs ASA into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Arcticzymes Technologies ASA and Ultimovacs ASA, you can compare the effects of market volatilities on Arcticzymes Technologies and Ultimovacs ASA and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Arcticzymes Technologies with a short position of Ultimovacs ASA. Check out your portfolio center. Please also check ongoing floating volatility patterns of Arcticzymes Technologies and Ultimovacs ASA.
Diversification Opportunities for Arcticzymes Technologies and Ultimovacs ASA
-0.51 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Arcticzymes and Ultimovacs is -0.51. Overlapping area represents the amount of risk that can be diversified away by holding Arcticzymes Technologies ASA and Ultimovacs ASA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ultimovacs ASA and Arcticzymes Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Arcticzymes Technologies ASA are associated (or correlated) with Ultimovacs ASA. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ultimovacs ASA has no effect on the direction of Arcticzymes Technologies i.e., Arcticzymes Technologies and Ultimovacs ASA go up and down completely randomly.
Pair Corralation between Arcticzymes Technologies and Ultimovacs ASA
Assuming the 90 days trading horizon Arcticzymes Technologies ASA is expected to under-perform the Ultimovacs ASA. But the stock apears to be less risky and, when comparing its historical volatility, Arcticzymes Technologies ASA is 2.0 times less risky than Ultimovacs ASA. The stock trades about -0.05 of its potential returns per unit of risk. The Ultimovacs ASA is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest 255.00 in Ultimovacs ASA on November 2, 2024 and sell it today you would lose (33.00) from holding Ultimovacs ASA or give up 12.94% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 99.04% |
| Values | Daily Returns |
Arcticzymes Technologies ASA vs. Ultimovacs ASA
Performance |
| Timeline |
| Arcticzymes Technologies |
| Ultimovacs ASA |
Arcticzymes Technologies and Ultimovacs ASA Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Arcticzymes Technologies and Ultimovacs ASA
The main advantage of trading using opposite Arcticzymes Technologies and Ultimovacs ASA positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Arcticzymes Technologies position performs unexpectedly, Ultimovacs ASA can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ultimovacs ASA will offset losses from the drop in Ultimovacs ASA's long position.| Arcticzymes Technologies vs. Bergenbio ASA | Arcticzymes Technologies vs. Photocure | Arcticzymes Technologies vs. Kitron ASA | Arcticzymes Technologies vs. Vow ASA |
| Ultimovacs ASA vs. Bergenbio ASA | Ultimovacs ASA vs. Nykode Therapeutics ASA | Ultimovacs ASA vs. PCI Biotech Holding |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Complementary Tools
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |